Comunidad Valencia 23.1.2021 Covid19
The Comunitat Valenciana has recorded 6,122 new cases of coronavirus confirmed by PCR or antigen testing since the last update, bringing the total number of […]
Month: January 2021
Safety of COVID-19 Vaccines – Paul-Ehrlich Institut
In Germany, the Paul-Ehrlich-Institut is the authority responsible for monitoring the safety of vaccines and biomedicines. For this purpose, the institute’s Division Pharmacovigilance collects and […]
Pfizer and BioNTech Publish Results of Study
Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture Today, Pfizer Inc. (NYSE: PFE) and BioNTech […]
Merck Announces Formation of Merck Digital Ethics Advisory Panel
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. Merck, a […]
Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine
We are in talks with the European Commission (EC) about an amendment to our existing supply agreement for COMIRNATY®, the Pfizer-BioNTech COVID-19 Vaccine. The amendment […]
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation
Associated with Rapid Transmission Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and […]
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in […]
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Merck today announced the acquisition of AmpTec a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). • Adds to Merck’s lipid manufacturing expertise, […]
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Companies enter into a collaboration and services agreement Bayer to support CureVac in numerous areas, including development and supply of CVnCoV CureVac benefits from Bayer´s […]